This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,891.49 fixed-price delivery order contract is for the supply of Clindamycin PH 1% gel, a pharmaceutical product. The contract has a period of performance through November 2024 and was awarded on November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. As a significant vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, AmerisourceBergen plays a critical role in supplying essential medical products to various government agencies.
Generated 2/18/25, 1:43 PM